Brigham and Women’s Hospital Adds to State of the Art Imaging Suite
New system at BWH is the first in the world to allow the capabilities of both MRI and x-ray angiography in a single suite.
Boston, MA, November 13, 2009 --(PR.com)-- Brigham and Women’s Hospital (BWH) has added the IMRISNV and IMRIScardio to the Advanced Multimodality Image Guided Operating (AMIGO) suite, combining the most advanced and complete image guidance capabilities in a single suite with the goal of delivering the best possible therapy to patients across a range of applications including neurological, neurovascular, oncological and cardiovascular disorders.
IMRISNV and IMRIScardio, which were recently cleared by the FDA, include an MR diagnostic center and interventional theatre, incorporating a Siemens wide bore 3T MRI and single plane angiography system. The system will permit rapid and seamless transitions between MR imaging and intervention without transporting the patient between modalities. MR images can be taken before and during procedures to assess tissue health, and can also be used in conjunction with the fluoroscopic images during interventional procedures.
The IMRIS system is the first in the world to allow the capabilities of both MRI and x-ray angiography in a single suite eliminating the need to transport the patient between modalities. In addition, no other system offers the same degree of safety for both the patient and the surgical environment. Ferenc Jolesz, MD, director of the Division of MRI and Image Guided Therapy Program at BWH, believes IMRIS’s capabilities best meet the hospital’s requirements for achieving the vision of AMIGO.
IMRIS and BWH have also entered into a five-year research initiative. The goals of the collaboration between IMRIS and BWH include the development of new applications, establishment of workflows and the validation of the benefits associated with new applications.
“We are extremely pleased to establish this important relationship with BWH and to have our system selected as the platform for AMIGO,” said David Graves, President & CEO, IMRIS. Internationally recognized as a pioneer in intra-operative MRI, BWH leads the U.S. National Center for Image Guided Therapy (NCIGT), under the leadership of Jolesz, MD, and Clare Tempany, MD, of the Radiology Department at BWH. “Partnering with BWH is a part of our overall vision to develop the next generation of applications, in support of further helping clinicians improve patient outcomes.”
About Brigham and Women's Hospital:-
Brigham and Women's Hospital (BWH) is a 777-bed nonprofit teaching affiliate of Harvard Medical School and a founding member of Partners HealthCare, an integrated health care delivery network. In July of 2008, the hospital opened the Carl J. and Ruth Shapiro Cardiovascular Center, the most advanced center of its kind. BWH is committed to excellence in patient care with expertise in virtually every specialty of medicine and surgery. The BWH medical preeminence dates back to 1832, and today that rich history in clinical care is coupled with its national leadership in quality improvement and patient safety initiatives and its dedication to educating and training the next generation of health care professionals. Through investigation and discovery conducted at its Biomedical Research Institute (BRI), BWH is an international leader in basic, clinical and translational research on human diseases, involving more than 860 physician-investigators and renowned biomedical scientists and faculty supported by more than $416 M in funding. BWH is also home to major landmark epidemiologic population studies, including the Nurses' and Physicians' Health Studies and the Women's Health Initiative. For more information about BWH, please visit http://www.brighamandwomens.org/
###
IMRISNV and IMRIScardio, which were recently cleared by the FDA, include an MR diagnostic center and interventional theatre, incorporating a Siemens wide bore 3T MRI and single plane angiography system. The system will permit rapid and seamless transitions between MR imaging and intervention without transporting the patient between modalities. MR images can be taken before and during procedures to assess tissue health, and can also be used in conjunction with the fluoroscopic images during interventional procedures.
The IMRIS system is the first in the world to allow the capabilities of both MRI and x-ray angiography in a single suite eliminating the need to transport the patient between modalities. In addition, no other system offers the same degree of safety for both the patient and the surgical environment. Ferenc Jolesz, MD, director of the Division of MRI and Image Guided Therapy Program at BWH, believes IMRIS’s capabilities best meet the hospital’s requirements for achieving the vision of AMIGO.
IMRIS and BWH have also entered into a five-year research initiative. The goals of the collaboration between IMRIS and BWH include the development of new applications, establishment of workflows and the validation of the benefits associated with new applications.
“We are extremely pleased to establish this important relationship with BWH and to have our system selected as the platform for AMIGO,” said David Graves, President & CEO, IMRIS. Internationally recognized as a pioneer in intra-operative MRI, BWH leads the U.S. National Center for Image Guided Therapy (NCIGT), under the leadership of Jolesz, MD, and Clare Tempany, MD, of the Radiology Department at BWH. “Partnering with BWH is a part of our overall vision to develop the next generation of applications, in support of further helping clinicians improve patient outcomes.”
About Brigham and Women's Hospital:-
Brigham and Women's Hospital (BWH) is a 777-bed nonprofit teaching affiliate of Harvard Medical School and a founding member of Partners HealthCare, an integrated health care delivery network. In July of 2008, the hospital opened the Carl J. and Ruth Shapiro Cardiovascular Center, the most advanced center of its kind. BWH is committed to excellence in patient care with expertise in virtually every specialty of medicine and surgery. The BWH medical preeminence dates back to 1832, and today that rich history in clinical care is coupled with its national leadership in quality improvement and patient safety initiatives and its dedication to educating and training the next generation of health care professionals. Through investigation and discovery conducted at its Biomedical Research Institute (BRI), BWH is an international leader in basic, clinical and translational research on human diseases, involving more than 860 physician-investigators and renowned biomedical scientists and faculty supported by more than $416 M in funding. BWH is also home to major landmark epidemiologic population studies, including the Nurses' and Physicians' Health Studies and the Women's Health Initiative. For more information about BWH, please visit http://www.brighamandwomens.org/
###
Contact
Brigham and Women’s Hospital
Suzanne Benz
(617) 534-1604
http://www.brighamandwomens.org/
75 Francis Street
Boston, MA 02115 USA
Contact
Suzanne Benz
(617) 534-1604
http://www.brighamandwomens.org/
75 Francis Street
Boston, MA 02115 USA
Categories